Modified EPOCH for high‐risk non‐Hodgkin lymphoma in sub‐Saharan Africa

Aggressive non‐Hodgkin lymphoma (NHL) is among the most common cancers in sub‐Saharan Africa (SSA), where CHOP is standard treatment and outcomes are poor. To address this, we treated 17 newly diagnosed adult patients in Malawi with Burkitt (n = 8), plasmablastic (n = 8), and primary effusion lympho...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Med
Hlavní autoři: Zuze, Takondwa, Ellis, Grace K., Kasonkanji, Edwards, Kaimila, Bongani, Nyasosela, Richard, Nyirenda, Ruth, Tomoka, Tamiwe, Mulenga, Maurice, Chikasema, Maria, Tewete, Blessings, Mtangwanika, Asekanadziwa, Chiyoyola, Sarah, Chimzimu, Fred, Kampani, Coxcilly, Mhango, Wilberforce, Nicholas, Simon, Randall, Cara, Montgomery, Nathan D., Fedoriw, George, Westmoreland, Katherine D., Painschab, Matthew S., Gopal, Satish
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2019
Témata:
Clinical Cancer Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6943163/
https://ncbi.nlm.nih.gov/pubmed/31705618
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2631
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky